BECKMAN COULTER ACCESS TESTOSTERONE, TOTAL; RADIOIMMUNOASSAY, TESTOSTERONES AND DIHYDROTESTOSTERONE
|
Back to Search Results |
|
Model Number 33560 |
Device Problem
High Test Results (2457)
|
Patient Problem
No Code Available (3191)
|
Event Date 04/21/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
The full patient identifier for this case is case (b)(4).The customer did not provide patient demographics such as age, date of birth, weight, ethnicity or race.The device was not returned for evaluation.System verification (system check) met specifications at the time of the event.It was reported that quality control was high and unacceptable (no further information provided).Calibration was expired at the time of the event.No hardware errors, flags or other assay issues were reported in conjunction with the event.A beckman coulter laboratory support specialist (lss) was dispatched to the customer site.The lss replaced the suspect reagent pack with a new reagent pack from the same reagent lot and tested the quality control samples and obtained acceptable results.The lss then retested samples from four of the eight female patients with the new reagent pack and obtained results which were lower and accordant with clinical expectation.The lss then retested the same four patient samples again with the suspect reagent pack and obtained results which were high and discordant with patient clinical expectation, and consistent with the original tests obtained for these patients.In conclusion, the cause of this event was traced to a specific reagent pack; however, the cause of the failure of the reagent pack cannot be determined with the available information.
|
|
Event Description
|
On (b)(6) 2020, the customer reported obtaining elevated testosterone (access testosterone) results for eight female patients involving the laboratory's unicel dxi 800 immunoassay system (part number 973100 and serial number (sn) (b)(4)).The customer did not provide a reference range; the beckman coulter testosterone reference range for females is: serum: <0.1 ¿ 0.75 ng/ml (<0.1 ¿ 2.60 nmol/l).Plasma: <0.1 ¿ 0.90 ng/ml (<0.1 ¿ 3.12 nmol/l).There was a report of change to patient treatment or management which occurred in connection with this event.The eight patients were prescribed medication to reduce testosterone levels (medication name, dosage and dates not provided) due to the elevated testosterone results.No further information was provided regarding change to or impact to patient care was reported in connection with this event.System performance indicators such as system check was passing within specifications at the time of the event; it was noted that the calibration, which was performed on (b)(6) 2019 was expired at the time of the event (calibration expired on 15nov2019).Quality control testing results were reported to be high and unacceptable.Customer¿s quality control ranges were not provided.No issues with sample collection were reported by the customer.No information regarding sample collection tubes, centrifugation, storage or other information was provided.Note: eight patients were impacted by this event; therefore, there are eight reports generated for this event, one for each patient: 2122870-2020-00028 will address patient 1.2122870-2020-00029 will address patient 2.2122870-2020-00030 will address patient 3.2122870-2020-00031 will address patient 4.2122870-2020-00032 will address patient 5.2122870-2020-00033 will address patient 6.2122870-2020-00034 will address patient 7.2122870-2020-00035 will address patient 8.
|
|
Search Alerts/Recalls
|
|
|